MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Amyloid load and cognitive decline in Parkinson’s disease: preliminary longitudinal findings

    M. Stark, T. Melzer, D. Myall, R. Keenan, T. Pitcher, KL. Horne, L. Livingston, M. Macaskill, J. Dalrymple-Alford, T. Anderson (Christchurch, New Zealand)

    Objective: To test for any association between amyloid deposition and future cognition in Parkinson’s disease, in a sample enriched for mild cognitive impairment. Background: Progressive…
  • 2019 International Congress

    The role of Synaptic vesicle protein 2A (SV2A) in patients with Parkinson’s disease dementia and Dementia with Lewy bodies: An in vivo [11C]UCB-J PET study

    H. Wilson, G. Dervenoulas, G. Pagano, A. Chandra, F. Niccolini, M. Esposito, R. Gunn, L. Ricciardi, E. Rabiner, D. Aarsland, M. Politis (London, United Kingdom)

    Objective: We aimed to investigate the role of synaptic vesicle glycoprotein 2A (SV2A) in Parkinson’s disease dementia (PDD) and Dementia with Lewy bodies (DLB) using…
  • 2019 International Congress

    Deep Brain Stimulation in Parkinson’s Disease: Experience of the Neurology Department of Marrakesh

    Z. Chourafa, M. Chraa, N. Louhab, N. Kissani (Marrakesh, Morocco)

    Objective: The authors report the experience of the Marrakesh University Hospital in Idiopathique Parkinson's surgery. Background: The treatment ofidiopathicParkinson's disease (IPD) remains symptomatic and relies…
  • 2019 International Congress

    Real World Clinical Outcomes Using a Novel Directional Lead from a Multicenter Registry of Deep Brain Stimulation for Parkinson’s Disease

    J. Vesper, R. Jain, A. Wang, H. Scholtes, V. Study Group, G. Deuschl (Düsseldorf, Germany)

    Objective: In this report, initial real-world outcomes using a directional lead with a Deep Brain Stimulation (DBS) system capable of multiple independent current source control…
  • 2019 International Congress

    Challenges in Parkinson’s Disease Diagnosis in a Patient with Ipsilateral Hemimelia

    G. Fabiani, FMB. Germiniani, HA. Teive (Curitiba, Brazil)

    Objective: Our main objective is to demonstrate the challenges involved in the diagnosis of parkinsonism in a patient with transverse failure of formation of the…
  • 2019 International Congress

    Freezing of Gait in Parkinson’s Disease: Risk Factors and Associated Nonmotor Symptoms

    D. Lichter, L. Hershey (Buffalo, NY, USA)

    Objective: To clarify risk factors for, and clinical associations of, freezing of gait (FOG) in Parkinson's disease (PD). Background: FOG is a disabling and incompletely…
  • 2019 International Congress

    Moaning: genetic analysis of a family with eight affected members

    M. Rossi, M. Gisatulin, C. Perandones, C. Klein, M. Merello, K. Lohmann (Buenos Aires, Argentina)

    Objective: To report the clinical and genetic evaluation of a five-generation family with eight members exhibiting moaning. Background: Moaning is characterized by low-tone abnormal involuntary,…
  • 2019 International Congress

    Gene Expression Profiling of depression in Huntington’s disease

    G. Colpo, N. Rocha, E. Furr Stimming, A. Lucio (Houston, TX, USA)

    Objective: This preliminary study was designed to investigate the gene expression profile by RNA-seq in HD patients with depression and without depression, and between subjects…
  • 2019 International Congress

    Neuroprotective and neurotrophic efficacy of Ginkgo biloba extracts against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington’s disease

    P. Kashyap, S. Gupta (Darbhanga, India)

    Objective: The present study examined the potential neuroprotective and neurotrophic efficacy of GBE against 3-nitropropionic acid (3-NP)-induced oxidative stress in a rat model of HD…
  • 2019 International Congress

    Huntington’s Disease Protein Huntingtin Associates with its own mRNA

    M. Rakhimova, M. Daropova (Tashkent, Uzbekistan)

    Objective: To investigate how Htt might affect RNA metabolism we set out to purify and analyze RNA associated with Htt. Background: The Huntington's disease (HD)…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley